date

Boddingtons Plastics: An update

Medical device manufacturer, Boddingtons, has lately been resourcing fast-tooling and moulding projects in relation to emergency procurement for the Covid-19 crisis.




date

‘Instant’ validated labelling platform available for ventilator manufacturers

Prisym ID, a provider of data-led label and artwork management solutions, is offering instant access to its Prisym 360 SaaS medical devices labelling solution, to support medtech manufacturers’ response to Covid-19.




date

Supreme Court Affirms: High Level of Proof Needed to Invalidate A Patent

Posted by Stephanie Fischer on June 10, 2011 at 3:29pm EDT on BIOtech Now The U.S. Supreme Court issued a favorable decision yesterday in the critical case of Microsoft v. i4i, in which Microsoft challenged the “clear and convincing evidence” standard traditionally used by courts in determining whether to invalidate an issued U.S. patent.   Microsoft argued for a lower “preponderance […]




date

Former Ergomed CEO appointed as Midatech’s Chief Financial Officer

Immunotherapy-focused pharmaceutical company Midatech Pharma has appointed Stephen Stamp as Chief Financial Officer (CFO) with immediate effect.

He will be replacing Nick Robbins-Cherry, who has stepped down after five years since joining in 2014. Robbins will nevertheless remain at Midatech until October to facilitate Stamp’s handover in an orderly fashion.

Stamp has most recently served as CEO of pharmaceutical firm Ergomed for two years, stepping down in January citing health reasons. Prior to this he was CFO at Ergomed for a year beginning in 2016.

read more




date

Biogen announces leadership updates

Biogen have announced updates to it senior leadership team with Alfred Sandrock being named Executive Vice President of Research and Development in addition to his responsibilities as Chief Medical Officer. Additionally Alphonse Galdes has been appointed as Executive Vice President of Pharmaceutical Operations and Technology.

In a statement, Michel Vounatsos, Chief Executive Officer at Biogen, said: “Both AI and Alphonse are seasoned and respected leaders at Biogen. Their accomplishment in the scientific community is well-recognised.

read more




date

FDA update on COVID-19 actions and advisements

Over the past week, the agency has issued guidances, taken action to accelerate treatments and put a stop to fraudulent treatments for the pandemic-causing virus.



  • Markets & Regulations

date

Weekly FDA COVID-19 update

The agency continues to remain busy overseeing and approving potential treatments and tests for the virus behind the global pandemic.



  • Markets & Regulations

date

Industry Update and COVID-19 Impact: Join Me for Two Live Video Webinars (May 1 and May 8)

This May, join Dr. Adam J. Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels, for two live video webinars:

You can purchase replays of these events using the links above.

Dr. Fein will help you navigate this challenging time in U.S. drug channels. These 75-minute live events will be broadcast via Zoom from the new Drug Channels Video studio. See details below.


You can sign up for either one of these crucial educational opportunities for only $300 per site per event. We are offering special pricing of $500 if you sign up for both events.

An unlimited number of people may watch at one location. However, we recognize that it may be difficult to gather your team in one location, so we are offering significant discounts for multiple viewing sites. Please contact Paula Fein (paula@drugchannelsinstitute.com) to get special pricing information for 5 or more locations. If you purchase access for multiple sites, we will contact you for the name and email address of a contact person at each location.

Read on for more information about the events.


To help people affected by COVID-19 and the caregivers who are supporting them , DCI will donate 20% of all profits from these events to The Center for Disaster Philanthropy’s COVID-19 Response Fund. This charity has earned a 4-star Charity Navigator rating and is a trusted philanthropic partner of Google, Coca Cola, UPS, Verizon, and many other organizations. The fund supports preparedness, containment, response, and recovery activities for those affected by the coronavirus and for the responders.


WHAT YOU WILL LEARN

We will help you and your team better understand key industry dynamics and how COVID-19 may alter the industry.

Dr. Fein will share DCI’s latest market data and trends from The 2020 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers.

Topics for Industry Update and COVID-19 Impact: Retail & Specialty Pharmacies:
  • The key trends for retail and specialty pharmacy markets
  • The new normal for prescription demand
  • How COVID-19 will change the U.S. payer mix
  • Will the 340B program be disrupted?
  • What’s next for specialty pharmacies
  • The outlook for prescription profits
  • The future for the drugstores’ front-end profits
  • New opportunities for pharmacists as providers
  • My reflections on life in a pandemic world and beyond

Topics for Industry Update and COVID-19 Impact: PBMs & Payers:
  • The key trends for PBMs
  • An update on the latest prescription data
  • What the changing U.S. payer mix means for PBMs and insurers
  • The outlook for benefit design
  • PBMs' role in Managed Medicaid
  • More on the 340B Drug Pricing Program
  • Disruption to the buy-and-bill channel
  • Promise and perils of vertical diversification
  • Further reflections on life in a pandemic world

PLUS: Dr. Fein will take your questions during the event. CLICK HERE to submit questions to Dr. Fein in advance of the events.

IMPORTANT STUFF TO KNOW
  • After you register, you will receive an email with the information you will need to access our live video webinar and add it to your calendar. We will also send you reminder emails one day and one hour before the event.
  • Watch and listen via any device with a web browser (computer, iPad, iPhone/Android, etc.)
  • After each event, you’ll receive a downloadable PDF with the event slides.
  • If your plans change and you can’t make it on May 1 or May 8, we will provide an opportunity to watch a replay of the live video events. Unfortunately, we are unable to offer refunds.
  • Pembroke Consulting clients receive free access to the webinar. Contact Tamra Feldman (admin@drugchannels.net) for details. We will automatically refund payments from anyone at a Pembroke client who purchases access using their corporate email account.

        




date

Amgen adds Otezla to the COVID-19 candidate list

Psoriasis therapy may be a potential treatment for COVID-19




date

Firms ready RNAi candidate for COVID-19 development

A collaboration in COVID-19 between immunology specialist Vir Biotechnology and Alnylam Pharmaceuticals…



  • Alnylam Pharmaceuticals/Anti-virals/Biotechnology/Cell and Gene Therapy/Coronavirus/Focus On/Public health/Research/USA/Vir Biotechnology/VIR-2703

date

Positive Phase III data for Lupin’s trichomoniasis candidate

India’s Lupin has announced positive top-line results from its pivotal Phase III clinical trial to…



  • Antibiotics and Infectious diseases/Drug Trial/India/Lupin/Pharmaceutical/Research/Solosec/Symbiomix Therapeutics/Women's health

date

Justice Department Reaches Settlement with Consolidated Multiple Listing Service Inc.

The Department has reached a proposed settlement with Consolidated Multiple Listing Service Inc. (CMLS) that requires CMLS to change its rules to allow low-priced and innovative brokers to compete with traditional brokers in the Columbia, S.C., area. The Department said the rules caused consumers to pay more for residential real estate brokerage services in the Columbia area.



  • OPA Press Releases

date

Former Pacific Consolidated Industries LP Executive Pleads Guilty in Connection with Bribes Paid to U.K. Ministry of Defense Official

The former director of sales and marketing for Pacific Consolidated Industries LP (PCI) pleaded guilty today to charges related to the bribery of a U.K. Ministry of Defense (UK-MOD) official in order to obtain lucrative equipment contracts with the U.K. Royal Air Force, in violation of the Foreign Corrupt Practices Act (FCPA).



  • OPA Press Releases

date

Justice Department and USDA Set Dates for Workshops to Explore Competition and Regulatory Issues in the Agriculture Industry

The all-day workshops, which will begin in March 2010, will be held in Alabama, Colorado, Iowa, Washington, D.C. and Wisconsin.



  • OPA Press Releases

date

Assistant Attorney General Thomas E. Perez Delivers Remarks at Naturalization Ceremony for 50 Citizenship Candidates

You are about to become our newest citizens. Hailing from 24 different countries, each of you represents a different culture, a different language, a different way of dress. But you will each now be American.




date

Department of Justice and USDA Announce Updated Schedule for Agriculture Workshop on March 12 in Iowa

The workshops, which were first announced by Attorney General Eric Holder and Agriculture Secretary Tom Vilsack on Aug. 5, 2009, are the first joint Department of Justice/USDA workshops ever to be held to discuss competition and regulatory issues in the agriculture industry.



  • OPA Press Releases

date

Three Arkansas Men Indicted for Burning Cross to Intimidate African-American Resident

James Bradley Branscum, Tony Branscum, both of Salado, Ark., and Curtis Coffee of Batesville, Ark., were indicted this week by a federal grand jury on charges related to their roles in burning a cross in the yard of an African-American resident in Salado on Aug. 28, 2010.



  • OPA Press Releases

date

Former California Congressional Candidate Sentenced to Federal Prison for Lying During Investigation

Tan Nguyen, 35, from Oceanside, Calif., was sentenced this morning by U.S. District Judge David O. Carter to one year and one day in federal prison for his conviction last year on a federal obstruction of justice charge stemming from lies he told California investigators about his involvement in a letter sent to Latino voters during his 2006 campaign for U.S. House of Representatives.



  • OPA Press Releases

date

Former Senator and Presidential Candidate John Edwards Charged for Alleged Role in Scheme to Violate Federal Campaign Finance Laws

A federal grand jury today returned a six-count indictment against former U.S. Senator and Presidential candidate John Edwards for allegedly participating in a scheme to violate federal campaign finance laws.



  • OPA Press Releases

date

Antitrust Division Issues Updated Merger Remedies Guide

The Department of Justice today released an updated version of the Antitrust Division’s Policy Guide to Merger Remedies.



  • OPA Press Releases

date

South San Francisco Food Processing Factory Will Pay Nearly $700,000 in Penalties, Spend $6 Million to Update Refrigeration System Safety

Columbus Manufacturing Inc., a wholly owned subsidiary of Columbus Foods LLC, has agreed to pay a penalty and make significant upgrades to settle Clean Air Act violations.



  • OPA Press Releases

date

Three Men Sentenced for Attempting to Intimidate African-American Students at a Louisiana Middle School

U.S. Magistrate Judge Karen Hayes sentenced James Lee Wallis Jr. to eight months in prison, Tony L. Johnson to six months in prison and Brian Wallis to five months in prison.



  • OPA Press Releases

date

Maryland Man Pleads Guilty for Conspiring to Hang a Noose to Intimidate an African-American Family

Joshua Wall, 20, pleaded guilty today in federal court in Baltimore for his involvement in hanging a dead raccoon from a noose on the porch of an African-American family.



  • OPA Press Releases

date

Congressional Candidate Pleads Guilty to Violation of the Federal Election Campaign Act

Former Congressional candidate Justin Lamar Sternad pleaded guilty today in Miami to violating the Federal Election Campaign Act during his 2012 campaign.



  • OPA Press Releases

date

Justice Department Releases Updated Protocol to Improve Standards for Responding to Rape and Sexual Assault

Attorney General Eric Holder today announced a revised version of the National Protocol for Sexual Assault Medical Forensic Examinations (SAFE Protocol, 2d.) The SAFE Protocol is a voluntary best practices guide to conducting sexual assault medical forensic examinations protocols.



  • OPA Press Releases

date

Justice Department Announces Update to Marijuana Enforcement Policy

Today, the U.S. Department of Justice announced an update to its federal marijuana enforcement policy in light of recent state ballot initiatives that legalize, under state law, the possession of small amounts of marijuana and provide for the regulation of marijuana production, processing, and sale.



  • OPA Press Releases

date

Department of Justice Provides Update on Gameover Zeus and Cryptolocker Disruption

The Justice Department today filed a status report with the United States District Court for the Western District of Pennsylvania updating the court on the progress in disrupting the Gameover Zeus botnet and the malicious software known as Cryptolocker



  • OPA Press Releases

date

Department of Justice Reaches Agreement with the Louisiana Supreme Court to Protect Bar Candidates with Disabilities

The Justice Department announced today that it has entered into a settlement agreement with the Louisiana Supreme Court that will resolve the department’s investigation of the court’s policies, practices and procedures for evaluating bar applicants with mental health disabilities. The department’s investigation found that during the Louisiana bar admissions process licensing entities based recommendations about bar admission on mental health diagnosis and treatment rather than conduct that would warrant denial of admission to the bar



  • OPA Press Releases

date

What’s New Health Canada? November 2019 Updates

By Alejandra Gomez Perez, M.Sc., Regulatory Affairs Associate   What’s New in: Therapeutic Products Directorate: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/what-new-drug-products-health-canada.html Biologics and Genetic Therapies Directorate: http://www.hc-sc.gc.ca/dhp-mps/brgtherap/update-miseajour/index-eng.php Medical Devices: https://www.canada.ca/en/health-canada/services/drugs-health-products/medical-devices/what-new.html Natural and Non-prescription Health Products Directorate: https://www.canada.ca/en/health-canada/services/drugs-health-products/natural-non-prescription/what-new.html   Updates from Health Canada Type of Update and Link Date Posted Notice – Update to Clinical Trial Site Information Form 29 November …

Continue reading »




date

What’s New Health Canada? January and February 2020 Updates

  By Alejandra Gomez Perez, M.Sc., Regulatory Affairs Associate   What’s New in:   Therapeutic Products Directorate: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/what-new-drug-products-health-canada.html Biologics and Genetic Therapies Directorate: http://www.hc-sc.gc.ca/dhp-mps/brgtherap/update-miseajour/index-eng.php Medical Devices: https://www.canada.ca/en/health-canada/services/drugs-health-products/medical-devices/what-new.html Natural and Non-prescription Health Products Directorate: https://www.canada.ca/en/health-canada/services/drugs-health-products/natural-non-prescription/what-new.html   Updates from Health Canada   Type of Update and Link Date Posted Notice: Product Monograph Implementation Plans 13 January 2020 …

Continue reading »




date

Vir Biotechnology, Alnylam Identify VIR-2703 Candidate For Treatment Of COVID-19

Vir Biotechnology, Inc. (VIR) and Alnylam Pharmaceuticals, Inc. (ALNY) announced Monday that they have selected a development candidate (DC) for VIR-2703 (ALN-COV), an investigational RNAi therapeutic targeting the SARS-CoV-2 (COVID-19) genome.




date

Sutro Biopharma Reports Updated Data From Ovarian Cancer Study

Sutro Biopharma Inc.'s (STRO) interim phase I updated clinical data for a dose-escalation study of antibody drug-conjugate STRO-002 in ovarian cancer has been encouraging.




date

RedHill Biopharma Provides Update On Compassionate Use Program With Opaganib

Biopharmaceutical company RedHill Biopharma Ltd. (RDHL) on Monday provided an additional update on the compassionate use program with its investigational drug, opaganib (Yeliva, ABC294640)1, in patients with confirmed SARS-CoV-2 infection (the cause of COVID-19) in Israel.




date

Alkemist Labs Moves to Larger Facility to Accommodate Growth, Expand Capacity

Alkemist Labs is pleased to announce a move to a new facility with over four times more space to expand capacity and accommodate continued growth.




date

Sanofi and Regeneron provide update on U.S. Phase 2/3 adaptive-designed trial in hospitalized COVID-19 patients

• Independent Data Monitoring Committee recommended continuing ongoing Phase 3 trial only in the more advanced “critical” group with Kevzara higher-dose versus placebo and discontinuing less advanced “severe” group




date

Impact of COVID-19 on FDA Enforcement and Approvals – Part 5 – FDA Provides Update to Shape Expectations on New Approvals

In response to written questions submitted last month regarding the potential for delays, FDA had stated that “CDER remains fully capable to continue daily activities, while responding to the public needs of the current COVID-19 outbreak.” In a subsequent blog … Continue reading




date

COVID-19 updates: 5 April 2020 – 30 April 2020

All the most important developments in the COVID-19 pandemic for pharmacists and their teams, as they happen.

To read the whole article click on the headline




date

Despite Late Changes and COVID-19, CCPA Enforcement Date Remains July 1

April 20, 2020 – With additional changes to the regulations still in administrative review and businesses grappling with pressing COVID-19 issues, a group of nearly 100 advertising trade associations, organizations and companies asked California Attorney General Xavier Becerra (D) to delay the July 1 enforcement date for the California Consumer Protection Act (CCPA). But it […]




date

Commission working on proposal to postpone MDR date of application for one year

After a statement on a press conference today by Stefan De keersmaecker that had many people very excited quickly, the official announcement came later in the afternoon: Here is what I think about this development. Work on a proposal ongoing The Commission announced that ‘work on a proposal to postpone the date of application’. This tells […]




date

MDR date of application move: politically a done deal now

With the overwhelming vote in the Parliament in favor of the Commission proposal to amend the MDR it is politically basically a done deal now that the MDR will be amended. After the vote there were people that immediately stated that the amendment was formally approved – not so. We are looking at law making […]




date

A phase two trial and a June goal: This week's updates on the race for a coronavirus vaccine

Experts caution that even promising early results don’t guarantee that vaccines will be widely available anytime soon.




date

Yokogawa Corporate Governance Report Updated (PDF: 650KB/34P)




date

Investors' Guide Updated




date

Nomination of Candidates for Director and Audit & Supervisory Board Member (PDF: 163KB/3P)




date

Nomination of Candidates for Director and Audit & Supervisory Board Member (PDF: 163KB/3P)




date

NTA NEET 2020 (UG) Postponed: Check Latest Updates!

NTA NEET 2020 has been postponed amid the coronavirus (COVID-19) pandemic. Check updates.




date

RBI Assistant Pre Result 2020 out @rbi.org.in: Check Prelims Cut off Marks & Mains Exam Date

RBI Assistant Result 2020 out @ rbi.co.in of the prelims exam held for the recruitment of over 900 vacancies in central bank. Check your result on direct link here and know your marks of RBI Assistant Prelims 2020. Know RBI Assistant cut off marks and Mains Exam Date.




date

RBI Assistant Scorecard Prelims 2020 link out @rbi.org.in: Download Here; Mains Exam Date Postponed

RBI Assistant Scorecard 2020 of prelims exam released @ rbi.org.in. Check your marks here on the direct link and download your marksheet. RBI Mains exam date postponed by Reserve Bank of India. The new exam date of RBI Assistant Mains 2020 will be revealed soon.




date

SBI Clerk 2020: Exam Date, Result, Cut Off, Syllabus, Pattern, Question Paper, Notification PDF

SBI Clerk 2020: SBI is soon going to release SBI Clerk Prelims Result 2020 @sbi.co.in. State Bank of India will conduct the SBI Clerk Mains exam on 19 April 2020 for recruitment of 8000 vacancies. Check here SBI Clerk Notification PDF 2020, exam updates, cut off marks, result date, prelims & mains syllabus, exam pattern, question paper, mock test and others. 




date

IBPS Exam Calendar 2020-2021: Check Exam Dates & Schedule of IBPS PO/Clerk/RRB/SO|Download PDF

IBPS Exam Calendar 2020-21 released @ ibps.in in PDF Download format. Check here exam dates and schedule of IBPS Recruitment 2020 of IBPS PO, IBPS Clerk, IBPS RRB and IBPS SO 2020 in banks. Download IBPS Calendar 2020 here.